Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio-Reference-Cited by-同舟云学术

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio

Published:2014-12-11 Issue:6 Volume:16 Page:370-374
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Martínez E¹,Ribera E²,Clotet B³,Estrada V⁴,Sanz J⁵,Berenguer J⁶,Rubio R⁷,Pulido F⁷,Larrousse M⁸,Curran A²,Negredo E³,Arterburn S⁹,Ferrer P¹⁰,Álvarez ML¹⁰

Affiliation:

1. Hospital Clinic IDIBAPS; University of Barcelona; Barcelona Spain

2. Hospital Universitari Vall d'Hebron; Infectious Diseases Division; Universitat Autonoma de Barcelona; Barcelona Spain

3. IrsiCaixa Foundation; Institut Germans Trias i Pujol; Universitat Autònoma de Barcelona; Badalona Spain

4. Instituto de Investigación Biomédica del Hospital Clínico San Carlos; Hospital Clínico San Carlos; Madrid Spain

5. Hospital Universitario de la Princesa; Instituto de Investigación Princesa; Madrid Spain

6. Infectious Diseases/HIV Unit; Hospital General Universitario Gregorio Marañón; Madrid Spain

7. Hospital Universitario 12 de Octubre; Madrid Spain

8. Hospital de Mataró; Barcelona Spain

9. Gilead Sciences Inc.; Foster City CA USA

10. Gilead Sciences SL; Madrid Spain

Funder

Gilead Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference18 articles.

1. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection;Mallal;AIDS,2000

2. Fat distribution in men with HIV infection;Bacchetti;J Acquir Immune Defic Syndr,2005

3. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial;Carr;JAMA,2002

4. The safety and efficacy of switching stavudine to tenofovir df in combination with lamivudine and efavirenz in hiv-1-infected patients: three-year follow-up after switching therapy;Madruga;HIV Clin Trials,2007

5. Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study;Martin;AIDS,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection;Antimicrobial Agents and Chemotherapy;2023-01-24

2. Reversibility of Lipoatrophy in HIV-Infected Patients Taking Antiretroviral Therapy: a Cohort Study with Ultrasound Assessment;Acta Clinica Croatica;2022

3. Prevalence of K65R in patients treated with tenofovir disoproxil fumarate: recommendations based on the Frankfurt HIV Cohort Study Resistance Database (FHCS-RD);MED MICROBIOL IMMUN;2016